{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T18:12:04Z","timestamp":1795284724954,"version":"4.10.3"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41593-018-0242-x","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T10:41:58Z","timestamp":1537353718000},"page":"1359-1369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1627,"title":["Microglia in neurodegeneration"],"prefix":"10.1038","volume":"21","author":[{"given":"Suzanne","family":"Hickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-6736","authenticated-orcid":false,"given":"Saef","family":"Izzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Morsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1498-1703","authenticated-orcid":false,"given":"Joseph","family":"El Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"242_CR1","first-page":"367","volume":"15","author":"P R\u00edo Hortega","year":"1918","unstructured":"R\u00edo Hortega, P. Noticia de un nuevo y f\u00e1cil m\u00e9todo para la coloraci\u00f3n de la neuroglia y el tejido conjuntivo. Trab. Lab. Invest. Biol. 15, 367\u2013378 (1918).","journal-title":"Trab. Lab. Invest. Biol."},{"key":"242_CR2","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1523\/JNEUROSCI.06-08-02163.1986","volume":"6","author":"D Giulian","year":"1986","unstructured":"Giulian, D. & Baker, T. J. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163\u20132178 (1986).","journal-title":"J. Neurosci."},{"key":"242_CR3","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","volume":"20","author":"S Jung","year":"2000","unstructured":"Jung, S. et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106\u20134114 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"242_CR4","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/nn1805","volume":"9","author":"SE Haynes","year":"2006","unstructured":"Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512\u20131519 (2006).","journal-title":"Nat. Neurosci."},{"key":"242_CR5","doi-asserted-by":"publisher","first-page":"10306","DOI":"10.1073\/pnas.1222895110","volume":"110","author":"G Yang","year":"2013","unstructured":"Yang, G., Parkhurst, C. N., Hayes, S. & Gan, W. B. Peripheral elevation of TNF-\u03b1 leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 110, 10306\u201310311 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"242_CR6","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman, S. E., Allison, E. K. & El Khoury, J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J. Neurosci. 28, 8354\u20138360 (2008).","journal-title":"J. Neurosci."},{"key":"242_CR7","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman, S. E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896\u20131905 (2013).","journal-title":"Nat. Neurosci."},{"key":"242_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"242_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson, L. J., Perry, V. H., Dri, P. & Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151\u2013170 (1990).","journal-title":"Neuroscience"},{"key":"242_CR10","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm1210-1369","volume":"16","author":"J El Khoury","year":"2010","unstructured":"El Khoury, J. Neurodegeneration and the neuroimmune system. Nat. Med. 16, 1369\u20131370 (2010).","journal-title":"Nat. Med."},{"key":"242_CR11","doi-asserted-by":"publisher","first-page":"a020560","DOI":"10.1101\/cshperspect.a020560","volume":"8","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff, R. M. & El Khoury, J. Microglia in health and disease. Cold Spring Harb. Perspect. Biol. 8, a020560 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"242_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nn.3318","volume":"16","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273\u2013280 (2013).","journal-title":"Nat. Neurosci."},{"key":"242_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nn.4547","volume":"20","author":"TL Tay","year":"2017","unstructured":"Tay, T. L. et al. A new fate mapping system reveals context-dependent random or clonal expansion of microglia. Nat. Neurosci. 20, 793\u2013803 (2017).","journal-title":"Nat. Neurosci."},{"key":"242_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753\u2013760 (2012).","journal-title":"Nat. Immunol."},{"key":"242_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278\u2013293.e9 (2017).","journal-title":"Neuron"},{"key":"242_CR16","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/nm.4189","volume":"22","author":"J Muffat","year":"2016","unstructured":"Muffat, J. et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358\u20131367 (2016).","journal-title":"Nat. Med."},{"key":"242_CR17","doi-asserted-by":"publisher","first-page":"eaai7635","DOI":"10.1126\/scitranslmed.aai7635","volume":"9","author":"KJ Ryan","year":"2017","unstructured":"Ryan, K. J. et al. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci. Transl. Med. 9, eaai7635 (2017).","journal-title":"Sci. Transl. Med."},{"key":"242_CR18","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","journal-title":"Science"},{"key":"242_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","volume":"532","author":"L Fourgeaud","year":"2016","unstructured":"Fourgeaud, L. et al. TAM receptors regulate multiple features of microglial physiology. Nature 532, 240\u2013244 (2016).","journal-title":"Nature"},{"key":"242_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature18283","volume":"534","author":"MJ Vasek","year":"2016","unstructured":"Vasek, M. J. et al. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature 534, 538\u2013543 (2016).","journal-title":"Nature"},{"key":"242_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","volume":"165","author":"H Lui","year":"2016","unstructured":"Lui, H. et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell 165, 921\u2013935 (2016).","journal-title":"Cell"},{"key":"242_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nn.3641","volume":"17","author":"Y Zhan","year":"2014","unstructured":"Zhan, Y. et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17, 400\u2013406 (2014).","journal-title":"Nat. Neurosci."},{"key":"242_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nn.2511","volume":"13","author":"M Fuhrmann","year":"2010","unstructured":"Fuhrmann, M. et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer\u2019s disease. Nat. Neurosci. 13, 411\u2013413 (2010).","journal-title":"Nat. Neurosci."},{"key":"242_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"242_CR25","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.4049\/jimmunol.1502562","volume":"196","author":"LM Healy","year":"2016","unstructured":"Healy, L. M. et al. MerTK is a functional regulator of myelin phagocytosis by human myeloid cells. J. Immunol. 196, 3375\u20133384 (2016).","journal-title":"J. Immunol."},{"key":"242_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"242_CR27","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20021546","volume":"197","author":"JB El Khoury","year":"2003","unstructured":"El Khoury, J. B. et al. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 197, 1657\u20131666 (2003).","journal-title":"J. Exp. Med."},{"key":"242_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J El Khoury","year":"2007","unstructured":"El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432\u2013438 (2007).","journal-title":"Nat. Med."},{"key":"242_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"242_CR30","first-page":"307","volume":"152","author":"SA Frautschy","year":"1998","unstructured":"Frautschy, S. A. et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152, 307\u2013317 (1998).","journal-title":"Am. J. Pathol."},{"key":"242_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neurobiolaging.2003.12.026","volume":"25","author":"MR D\u2019Andrea","year":"2004","unstructured":"D\u2019Andrea, M. R., Cole, G. M. & Ard, M. D. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol. Aging 25, 675\u2013683 (2004).","journal-title":"Neurobiol. Aging"},{"key":"242_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0006-8993(90)91496-4","volume":"523","author":"I Tooyama","year":"1990","unstructured":"Tooyama, I., Kimura, H., Akiyama, H. & McGeer, P. L. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer\u2019s disease. Brain Res. 523, 273\u2013280 (1990).","journal-title":"Brain Res."},{"key":"242_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/acel.12522","volume":"16","author":"E Martin","year":"2017","unstructured":"Martin, E., Boucher, C., Fontaine, B. & Delarasse, C. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer\u2019s disease models: effects of aging and amyloid pathology. Aging Cell 16, 27\u201338 (2017).","journal-title":"Aging Cell"},{"key":"242_CR34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"242_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"242_CR36","unstructured":"El Khoury, J. & Hickman, S.E. Mechanisms of amyloid-beta clearance in Alzheimer\u2019s disease. in Research Progress in Alzheimer\u2019s Disease and Dementia, vol. 4. (ed. Sun, M.-K.) 37\u201366 (Nova Science Publishers, Hauppauge, NY, USA, 2009)."},{"key":"242_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3030","volume":"4","author":"D Frenkel","year":"2013","unstructured":"Frenkel, D. et al. Scara1 deficiency impairs clearance of soluble amyloid-\u03b2 by mononuclear phagocytes and accelerates Alzheimer\u2019s-like disease progression. Nat. Commun. 4, 2030 (2013).","journal-title":"Nat. Commun."},{"key":"242_CR38","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/382716a0","volume":"382","author":"J El Khoury","year":"1996","unstructured":"El Khoury, J. et al. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382, 716\u2013719 (1996).","journal-title":"Nature"},{"key":"242_CR39","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"242_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0002-9440(10)64354-4","volume":"160","author":"IS Coraci","year":"2002","unstructured":"Coraci, I. S. et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer\u2019s disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160, 101\u2013112 (2002).","journal-title":"Am. J. Pathol."},{"key":"242_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00281-015-0518-0","volume":"37","author":"M Gold","year":"2015","unstructured":"Gold, M. & El Khoury, J. \u03b2-amyloid, microglia, and the inflammasome in Alzheimer\u2019s disease. Semin. Immunopathol. 37, 607\u2013611 (2015).","journal-title":"Semin. Immunopathol."},{"key":"242_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas, C. et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature 552, 355\u2013361 (2017).","journal-title":"Nature"},{"issue":"Suppl 1","key":"242_CR43","first-page":"S295","volume":"33","author":"SE Hickman","year":"2013","unstructured":"Hickman, S. E. & El Khoury, J. The neuroimmune system in Alzheimer\u2019s disease: the glass is half full. J. Alzheimers Dis. 33(Suppl 1), S295\u2013S302 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"242_CR44","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B. P. & LaFerla, F. M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease. Neurobiol. Aging 24, 1063\u20131070 (2003).","journal-title":"Neurobiol. Aging"},{"key":"242_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.semnuclmed.2016.09.006","volume":"47","author":"VL Villemagne","year":"2017","unstructured":"Villemagne, V. L. et al. A\u03b2-amyloid and tau imaging in dementia. Semin. Nucl. Med. 47, 75\u201388 (2017).","journal-title":"Semin. Nucl. Med."},{"key":"242_CR46","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/glia.22966","volume":"64","author":"K Bisht","year":"2016","unstructured":"Bisht, K. et al. Dark microglia: a new phenotype predominantly associated with pathological states. Glia 64, 826\u2013839 (2016).","journal-title":"Glia"},{"key":"242_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer, I. et al. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J. Neuropathol. Exp. Neurol. 73, 81\u201397 (2014).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"242_CR48","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584\u20131593 (2015).","journal-title":"Nat. Neurosci."},{"key":"242_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JAD-150704","volume":"50","author":"M Bol\u00f3s","year":"2016","unstructured":"Bol\u00f3s, M. et al. Direct evidence of internalization of tau by microglia in vitro and in vivo. J. Alzheimers Dis. 50, 77\u201387 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"242_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-56","volume":"7","author":"DC Lee","year":"2010","unstructured":"Lee, D. C. et al. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J. Neuroinflammation 7, 56 (2010).","journal-title":"J. Neuroinflammation"},{"key":"242_CR51","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman, S. et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J. Biol. Chem. 287, 3842\u20133849 (2012).","journal-title":"J. Biol. Chem."},{"key":"242_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca, M. S. et al. Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 11, 600\u20137.e1 (2015).","journal-title":"Alzheimers Dement."},{"key":"242_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-016-0382-8","volume":"4","author":"JD Cherry","year":"2016","unstructured":"Cherry, J. D. et al. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol. Commun. 4, 112 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"242_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"242_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","volume":"68","author":"K Bhaskar","year":"2010","unstructured":"Bhaskar, K. et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19\u201331 (2010).","journal-title":"Neuron"},{"key":"242_CR56","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.neurobiolaging.2012.12.011","volume":"34","author":"KR Nash","year":"2013","unstructured":"Nash, K. R. et al. Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy. Neurobiol. Aging 34, 1540\u20131548 (2013).","journal-title":"Neurobiol. Aging"},{"key":"242_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller, S. M. et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol. Neurodegener. 12, 74 (2017).","journal-title":"Mol. Neurodegener."},{"key":"242_CR58","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","volume":"42","author":"H Deng","year":"2018","unstructured":"Deng, H., Wang, P. & Jankovic, J. The genetics of Parkinson disease. Ageing Res. Rev. 42, 72\u201385 (2018).","journal-title":"Ageing Res. Rev."},{"issue":"Suppl 1","key":"242_CR59","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. Neuropathology of Parkinson disease. Parkinsonism Relat. Disord. 46(Suppl 1), S30\u2013S33 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"242_CR60","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38, 1285\u20131291 (1988).","journal-title":"Neurology"},{"key":"242_CR61","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard, A. et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol. Dis. 21, 404\u2013412 (2006).","journal-title":"Neurobiol. Dis."},{"key":"242_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday, G. M. & Stevens, C. H. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov. Disord. 26, 6\u201317 (2011).","journal-title":"Mov. Disord."},{"key":"242_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-2-14","volume":"2","author":"E Croisier","year":"2005","unstructured":"Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K. & Graeber, M. B. Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J. Neuroinflammation 2, 14 (2005).","journal-title":"J. Neuroinflammation"},{"key":"242_CR64","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","volume":"29","author":"X Su","year":"2008","unstructured":"Su, X. et al. Synuclein activates microglia in a model of Parkinson\u2019s disease. Neurobiol. Aging 29, 1690\u20131701 (2008).","journal-title":"Neurobiol. Aging"},{"key":"242_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim, C. et al. Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562 (2013).","journal-title":"Nat. Commun."},{"key":"242_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann, T. et al. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 133, 13\u201324 (2017).","journal-title":"Acta Neuropathol."},{"key":"242_CR67","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","volume":"211","author":"R Yamasaki","year":"2014","unstructured":"Yamasaki, R. et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J. Exp. Med. 211, 1533\u20131549 (2014).","journal-title":"J. Exp. Med."},{"key":"242_CR68","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy, T. et al. Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis. Brain 140, 1900\u20131913 (2017).","journal-title":"Brain"},{"key":"242_CR69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-444-63233-3.00017-8","volume":"147","author":"R Ghosh","year":"2018","unstructured":"Ghosh, R. & Tabrizi, S. J. Huntington disease. Handb. Clin. Neurol. 147, 255\u2013278 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"242_CR70","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai, Y. F. et al. Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130, 1759\u20131766 (2007).","journal-title":"Brain"},{"key":"242_CR71","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese, N. et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66, 1638\u20131643 (2006).","journal-title":"Neurology"},{"key":"242_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp, E. et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161\u2013172 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"242_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti, A. et al. Mutant huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat. Neurosci. 17, 513\u2013521 (2014).","journal-title":"Nat. Neurosci."},{"key":"242_CR74","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","volume":"127","author":"D Lall","year":"2017","unstructured":"Lall, D. & Baloh, R. H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Invest. 127, 3250\u20133258 (2017).","journal-title":"J. Clin. Invest."},{"key":"242_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel, J. S. et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221\u2013235 (2004).","journal-title":"Ann. Neurol."},{"key":"242_CR76","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","volume":"15","author":"MR Turner","year":"2004","unstructured":"Turner, M. R. et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 15, 601\u2013609 (2004).","journal-title":"Neurobiol. Dis."},{"key":"242_CR77","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"242_CR78","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1073\/pnas.0802556105","volume":"105","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka, K. et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. USA 105, 7594\u20137599 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"242_CR79","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1093\/hmg\/ddt259","volume":"22","author":"S Apolloni","year":"2013","unstructured":"Apolloni, S., Amadio, S., Montilli, C., Volont\u00e9, C. & D\u2019Ambrosi, N. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 4102\u20134116 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"242_CR80","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#","volume":"23","author":"ED Hall","year":"1998","unstructured":"Hall, E. D., Oostveen, J. A. & Gurney, M. E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23, 249\u2013256 (1998).","journal-title":"Glia"},{"key":"242_CR81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao, B., Zhao, W., Beers, D. R., Henkel, J. S. & Appel, S. H. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 237, 147\u2013152 (2012).","journal-title":"Exp. Neurol."},{"key":"242_CR82","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"AE Frakes","year":"2014","unstructured":"Frakes, A. E. et al. Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis. Neuron 81, 1009\u20131023 (2014).","journal-title":"Neuron"},{"key":"242_CR83","doi-asserted-by":"publisher","first-page":"13046","DOI":"10.1073\/pnas.1002396107","volume":"107","author":"F Meissner","year":"2010","unstructured":"Meissner, F., Molawi, K. & Zychlinsky, A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc. Natl. Acad. Sci. USA 107, 13046\u201313050 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"242_CR84","first-page":"659","volume":"118","author":"MM Harraz","year":"2008","unstructured":"Harraz, M. M. et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 118, 659\u2013670 (2008).","journal-title":"J. Clin. Invest."},{"key":"242_CR85","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/glia.20919","volume":"58","author":"W Zhao","year":"2010","unstructured":"Zhao, W. et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231\u2013243 (2010).","journal-title":"Glia"},{"key":"242_CR86","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.neuron.2015.10.027","volume":"88","author":"JG O\u2019Rourke","year":"2015","unstructured":"O\u2019Rourke, J. G. et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS\/FTD. Neuron 88, 892\u2013901 (2015).","journal-title":"Neuron"},{"key":"242_CR87","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","volume":"351","author":"JG O\u2019Rourke","year":"2016","unstructured":"O\u2019Rourke, J. G. et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324\u20131329 (2016).","journal-title":"Science"},{"key":"242_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","volume":"21","author":"KJ Spiller","year":"2018","unstructured":"Spiller, K. J. et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 21, 329\u2013340 (2018).","journal-title":"Nat. Neurosci."},{"key":"242_CR89","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuron.2017.05.037","volume":"95","author":"RC Paolicelli","year":"2017","unstructured":"Paolicelli, R. C. et al. TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron 95, 297\u2013308.e6 (2017).","journal-title":"Neuron"},{"key":"242_CR90","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s12035-017-0522-6","volume":"55","author":"L Iaccarino","year":"2018","unstructured":"Iaccarino, L. et al. An in vivo 11C-(R)-PK11195 PET and in vitro pathology study of microglia activation in Creutzfeldt-Jakob disease. Mol. Neurobiol. 55, 2856\u20132868 (2018).","journal-title":"Mol. Neurobiol."},{"key":"242_CR91","first-page":"e01457","volume":"92","author":"T Yamasaki","year":"2017","unstructured":"Yamasaki, T., Suzuki, A., Hasebe, R. & Horiuchi, M. Flow cytometric detection of PrPSc in neurons and glial cells from prion-infected mouse brains. J. Virol. 92, e01457\u201317 (2017).","journal-title":"J. Virol."},{"key":"242_CR92","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nn2028","volume":"11","author":"J Falsig","year":"2008","unstructured":"Falsig, J. et al. A versatile prion replication assay in organotypic brain slices. Nat. Neurosci. 11, 109\u2013117 (2008).","journal-title":"Nat. Neurosci."},{"key":"242_CR93","doi-asserted-by":"publisher","first-page":"e1004531","DOI":"10.1371\/journal.ppat.1004531","volume":"10","author":"S Sorce","year":"2014","unstructured":"Sorce, S. et al. The role of the NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathog. 10, e1004531 (2014).","journal-title":"PLoS Pathog."},{"key":"242_CR94","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1172\/JCI90605","volume":"127","author":"A Aguzzi","year":"2017","unstructured":"Aguzzi, A. & Zhu, C. Microglia in prion diseases. J. Clin. Invest. 127, 3230\u20133239 (2017).","journal-title":"J. Clin. Invest."},{"key":"242_CR95","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1007\/s00018-012-1140-0","volume":"69","author":"I Hafner-Bratkovi\u010d","year":"2012","unstructured":"Hafner-Bratkovi\u010d, I., Ben\u010dina, M., Fitzgerald, K. A., Golenbock, D. & Jerala, R. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1\u03b2 and neuronal toxicity. Cell. Mol. Life Sci. 69, 4215\u20134228 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"242_CR96","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12031-013-0002-z","volume":"51","author":"WL Xie","year":"2013","unstructured":"Xie, W. L. et al. Abnormal activation of microglia accompanied with disrupted CX3CR1\/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K. J. Mol. Neurosci. 51, 919\u2013932 (2013).","journal-title":"J. Mol. Neurosci."},{"key":"242_CR97","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/glia.21070","volume":"58","author":"MM Hughes","year":"2010","unstructured":"Hughes, M. M., Field, R. H., Perry, V. H., Murray, C. L. & Cunningham, C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 58, 2017\u20132030 (2010).","journal-title":"Glia"},{"key":"242_CR98","doi-asserted-by":"publisher","first-page":"13433","DOI":"10.1128\/JVI.02072-13","volume":"87","author":"K Sakai","year":"2013","unstructured":"Sakai, K. et al. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation. J. Virol. 87, 13433\u201313445 (2013).","journal-title":"J. Virol."},{"key":"242_CR99","doi-asserted-by":"publisher","first-page":"e30756","DOI":"10.1371\/journal.pone.0030756","volume":"7","author":"M Kouadir","year":"2012","unstructured":"Kouadir, M. et al. CD36 participates in PrP(106-126)-induced activation of microglia. PLoS One 7, e30756 (2012).","journal-title":"PLoS One"},{"key":"242_CR100","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.pa.36.040196.000503","volume":"36","author":"NA Simonian","year":"1996","unstructured":"Simonian, N. A. & Coyle, J. T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83\u2013106 (1996).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"Pt B","key":"242_CR101","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.brainres.2015.08.031","volume":"1628","author":"GC Brown","year":"2015","unstructured":"Brown, G. C. & Vilalta, A. How microglia kill neurons. Brain Res. 1628(Pt B), 288\u2013297 (2015).","journal-title":"Brain Res."},{"key":"242_CR102","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","volume":"30","author":"I Maezawa","year":"2010","unstructured":"Maezawa, I. & Jin, L. W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J. Neurosci. 30, 5346\u20135356 (2010).","journal-title":"J. Neurosci."},{"key":"242_CR103","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1074\/jbc.M306183200","volume":"279","author":"L Gan","year":"2004","unstructured":"Gan, L. et al. Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach. J. Biol. Chem. 279, 5565\u20135572 (2004).","journal-title":"J. Biol. Chem."},{"key":"242_CR104","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuroscience.2009.02.080","volume":"160","author":"CC Leonardo","year":"2009","unstructured":"Leonardo, C. C., Hall, A. A., Collier, L. A., Gottschall, P. E. & Pennypacker, K. R. Inhibition of gelatinase activity reduces neural injury in an ex vivo model of hypoxia-ischemia. Neuroscience 160, 755\u2013766 (2009).","journal-title":"Neuroscience"},{"key":"242_CR105","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","volume":"88","author":"SE Hickman","year":"2014","unstructured":"Hickman, S. E. & El Khoury, J. TREM2 and the neuroimmunology of Alzheimer\u2019s disease. Biochem. Pharmacol. 88, 495\u2013498 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"242_CR106","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 Binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"242_CR107","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"242_CR108","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. TREM2 is a receptor for \u03b2-amyloid that mediates microglial function. Neuron 97, 1023\u20131031.e7 (2018).","journal-title":"Neuron"},{"key":"242_CR109","doi-asserted-by":"publisher","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet, M. et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury. Sci. Transl. Med. 8, 369ra178 (2016).","journal-title":"Sci. Transl. Med."},{"key":"242_CR110","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi, K., Rochford, C. D. & Neumann, H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201, 647\u2013657 (2005).","journal-title":"J. Exp. Med."},{"key":"242_CR111","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667\u2013675 (2016).","journal-title":"J. Exp. Med."},{"key":"242_CR112","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663.e13 (2017).","journal-title":"Cell"},{"key":"242_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello, C., Yuan, P., Schain, A. & Grutzendler, J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat. Commun. 6, 6176 (2015).","journal-title":"Nat. Commun."},{"key":"242_CR114","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","volume":"12","author":"TR Jay","year":"2017","unstructured":"Jay, T. R., von Saucken, V. E. & Landreth, G. E. TREM2 in neurodegenerative diseases. Mol. Neurodegener. 12, 56 (2017).","journal-title":"Mol. Neurodegener."},{"key":"242_CR115","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song, W. M. et al. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J. Exp. Med. 215, 745\u2013760 (2018).","journal-title":"J. Exp. Med."},{"key":"242_CR116","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20030027","volume":"198","author":"J Paloneva","year":"2003","unstructured":"Paloneva, J. et al. DAP12\/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J. Exp. Med. 198, 669\u2013675 (2003).","journal-title":"J. Exp. Med."},{"key":"242_CR117","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1440-1789.2010.01174.x","volume":"31","author":"J Satoh","year":"2011","unstructured":"Satoh, J. et al. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains. Neuropathology 31, 363\u2013375 (2011).","journal-title":"Neuropathology"},{"key":"242_CR118","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet, M. et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol. Med. 8, 466\u2013476 (2016).","journal-title":"EMBO Mol. Med."},{"key":"242_CR119","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bpa.12190","volume":"25","author":"LF Lue","year":"2015","unstructured":"Lue, L. F. et al. TREM2 protein expression changes correlate with Alzheimer\u2019s disease neurodegenerative pathologies in post-mortem temporal cortices. Brain Pathol. 25, 469\u2013480 (2015).","journal-title":"Brain Pathol."},{"key":"242_CR120","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jalz.2014.12.009","volume":"11","author":"CM Lill","year":"2015","unstructured":"Lill, C. M. et al. The role of TREM2 R47H as a risk factor for Alzheimer\u2019s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson\u2019s disease. Alzheimers Dement. 11, 1407\u20131416 (2015).","journal-title":"Alzheimers Dement."},{"key":"242_CR121","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","volume":"71","author":"J Cady","year":"2014","unstructured":"Cady, J. et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 71, 449\u2013453 (2014).","journal-title":"JAMA Neurol."},{"key":"242_CR122","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.neurobiolaging.2015.08.019","volume":"36","author":"T Jiang","year":"2015","unstructured":"Jiang, T. et al. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice. Neurobiol. Aging 36, 3176\u20133186 (2015).","journal-title":"Neurobiol. Aging"},{"key":"242_CR123","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns, C. E. G. et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc. Natl. Acad. Sci. USA 114, 11524\u201311529 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"242_CR124","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/187152710791011982","volume":"9","author":"SE Hickman","year":"2010","unstructured":"Hickman, S. E. & El Khoury, J. Mechanisms of mononuclear phagocyte recruitment in Alzheimer\u2019s disease. CNS Neurol. Disord. Drug Targets 9, 168\u2013173 (2010).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"242_CR125","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0165-5728(01)00259-4","volume":"115","author":"V Zujovic","year":"2001","unstructured":"Zujovic, V., Schussler, N., Jourdain, D., Duverger, D. & Taupin, V. In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J. Neuroimmunol. 115, 135\u2013143 (2001).","journal-title":"J. Neuroimmunol."},{"key":"242_CR126","doi-asserted-by":"publisher","first-page":"17091","DOI":"10.1523\/JNEUROSCI.4403-10.2010","volume":"30","author":"Z Liu","year":"2010","unstructured":"Liu, Z., Condello, C., Schain, A., Harb, R. & Grutzendler, J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-\u03b2 phagocytosis. J. Neurosci. 30, 17091\u201317101 (2010).","journal-title":"J. Neurosci."},{"key":"242_CR127","doi-asserted-by":"publisher","first-page":"14592","DOI":"10.1523\/JNEUROSCI.0539-12.2012","volume":"32","author":"JM Morganti","year":"2012","unstructured":"Morganti, J. M. et al. The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson\u2019s disease. J. Neurosci. 32, 14592\u201314601 (2012).","journal-title":"J. Neurosci."},{"key":"242_CR128","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nn1715","volume":"9","author":"AE Cardona","year":"2006","unstructured":"Cardona, A. E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917\u2013924 (2006).","journal-title":"Nat. Neurosci."},{"key":"242_CR129","doi-asserted-by":"publisher","first-page":"e0140566","DOI":"10.1371\/journal.pone.0140566","volume":"10","author":"AD Thome","year":"2015","unstructured":"Thome, A. D., Standaert, D. G. & Harms, A. S. Fractalkine signaling regulates the inflammatory response in an \u03b1-synuclein model of Parkinson disease. PLoS One 10, e0140566 (2015).","journal-title":"PLoS One"},{"key":"242_CR130","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cell.2014.01.064","volume":"157","author":"I Martin","year":"2014","unstructured":"Martin, I. et al. Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson\u2019s disease. Cell 157, 472\u2013485 (2014).","journal-title":"Cell"},{"key":"242_CR131","doi-asserted-by":"publisher","first-page":"e96528","DOI":"10.1371\/journal.pone.0096528","volume":"9","author":"A Lopez-Lopez","year":"2014","unstructured":"Lopez-Lopez, A. et al. CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis. PLoS One 9, e96528 (2014).","journal-title":"PLoS One"},{"key":"242_CR132","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mus.25653","volume":"57","author":"A Calvo","year":"2018","unstructured":"Calvo, A. et al. Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: a population-based study. Muscle Nerve 57, 212\u2013216 (2018).","journal-title":"Muscle Nerve"},{"key":"242_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-15-44","volume":"15","author":"J Grizenkova","year":"2014","unstructured":"Grizenkova, J., Akhtar, S., Brandner, S., Collinge, J. & Lloyd, S. E. Microglial Cx3cr1 knockout reduces prion disease incubation time in mice. BMC Neurosci. 15, 44 (2014).","journal-title":"BMC Neurosci."},{"key":"242_CR134","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1099\/jgv.0.000442","volume":"97","author":"JF Striebel","year":"2016","unstructured":"Striebel, J. F., Race, B., Carroll, J. A., Phillips, K. & Chesebro, B. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice. J. Gen. Virol. 97, 1481\u20131487 (2016).","journal-title":"J. Gen. Virol."},{"key":"242_CR135","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.4049\/jimmunol.1700373","volume":"198","author":"MR PrabhuDas","year":"2017","unstructured":"PrabhuDas, M. R. et al. A consensus definitive classification of scavenger receptors and their roles in health and disease. J. Immunol. 198, 3775\u20133789 (2017).","journal-title":"J. Immunol."},{"key":"242_CR136","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbi.2017.12.007","volume":"69","author":"F Cornejo","year":"2018","unstructured":"Cornejo, F. et al. Scavenger receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer\u2019s disease pathophysiology. Brain Behav. Immun. 69, 336\u2013350 (2018).","journal-title":"Brain Behav. Immun."},{"key":"242_CR137","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2017.01.009","volume":"135","author":"O \u0160er\u00fd","year":"2017","unstructured":"\u0160er\u00fd, O. et al. CD36 gene polymorphism is associated with Alzheimer\u2019s disease. Biochimie 135, 46\u201353 (2017).","journal-title":"Biochimie"},{"key":"242_CR138","doi-asserted-by":"publisher","first-page":"34914","DOI":"10.1074\/jbc.M111.232116","volume":"286","author":"K Wilkinson","year":"2011","unstructured":"Wilkinson, K., Boyd, J. D., Glicksman, M., Moore, K. J. & El Khoury, J. A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36. J. Biol. Chem. 286, 34914\u201334922 (2011).","journal-title":"J. Biol. Chem."},{"key":"242_CR139","doi-asserted-by":"publisher","first-page":"11414","DOI":"10.1523\/JNEUROSCI.2127-10.2010","volume":"30","author":"N Origlia","year":"2010","unstructured":"Origlia, N. et al. Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex. J. Neurosci. 30, 11414\u201311425 (2010).","journal-title":"J. Neurosci."},{"key":"242_CR140","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000261723","volume":"6","author":"I Vodopivec","year":"2009","unstructured":"Vodopivec, I. et al. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice. Neurodegener. Dis. 6, 270\u2013280 (2009).","journal-title":"Neurodegener. Dis."},{"key":"242_CR141","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awx198","volume":"140","author":"BP Chitramuthu","year":"2017","unstructured":"Chitramuthu, B. P., Bennett, H. P. J. & Bateman, A. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease. Brain 140, 3081\u20133104 (2017).","journal-title":"Brain"},{"key":"242_CR142","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/ana.25085","volume":"82","author":"Y Gong","year":"2017","unstructured":"Gong, Y. et al. Microglial dysfunction as a key pathological change in adrenomyeloneuropathy. Ann. Neurol. 82, 813\u2013827 (2017).","journal-title":"Ann. Neurol."},{"key":"242_CR143","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00415-014-7630-2","volume":"262","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis. J. Neurol. 262, 814\u2013822 (2015).","journal-title":"J. Neurol."},{"key":"242_CR144","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nm.3672","volume":"20","author":"SS Minami","year":"2014","unstructured":"Minami, S. S. et al. Progranulin protects against amyloid \u03b2 deposition and toxicity in Alzheimer\u2019s disease mouse models. Nat. Med. 20, 1157\u20131164 (2014).","journal-title":"Nat. Med."},{"key":"242_CR145","doi-asserted-by":"publisher","first-page":"e97032","DOI":"10.1371\/journal.pone.0097032","volume":"9","author":"JM Van Kampen","year":"2014","unstructured":"Van Kampen, J. M., Baranowski, D. & Kay, D. G. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. PLoS One 9, e97032 (2014).","journal-title":"PLoS One"},{"key":"242_CR146","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/01.wnl.0000289191.54852.75","volume":"71","author":"K Sleegers","year":"2008","unstructured":"Sleegers, K. et al. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 71, 253\u2013259 (2008).","journal-title":"Neurology"},{"key":"242_CR147","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965\u2013977 (2015).","journal-title":"Nat. Neurosci."},{"key":"242_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7, 13537 (2017).","journal-title":"Sci. Rep."},{"key":"242_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter, M. R. et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease. Sci. Rep. 6, 30028 (2016).","journal-title":"Sci. Rep."},{"key":"242_CR150","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0242-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0242-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0242-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:09:33Z","timestamp":1650391773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-018-0242-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":150,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1038\/s41593-018-0242-x","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}